Innate sensors for Gram-positive bacteria

Current Opinion in Immunology

Volumn 15, Issue 4, 2003, Pages 408-415

  Weber, Joerg R ^a   Moreillon, Philippe ^b   Tuomanen, Elaine I ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; C REACTIVE PROTEIN; CELL RECEPTOR; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; PHOSPHORYLCHOLINE; SCAVENGER RECEPTOR; TEICHOIC ACID; TOLL LIKE RECEPTOR 2;

BACTERIAL CELL WALL; CELL STRUCTURE; GRAM POSITIVE BACTERIUM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; NONHUMAN; REVIEW; SENSOR; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION;

EID: 0042905870     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00078-5     Document Type: Review

References (70)

1. Tuomanen E., Liu H., Hengstler B., Zak O., Tomasz A. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151:1985;859-868.
2. Tuomanen E., Rich R., Zak O. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am. Rev. Respir. Dis. 135:1987;869-874.
3. Laman J., Schoneveld A., Moll F., vanMeurs M., Pasterkamp G. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am. J. Cardiol. 90:2002;119-123.
4. Schneider O., Michel U., Zysk G., Dubuis O., Nau R. Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations. Neurology. 53:1999;1584-1587.
5. Reisenfeld-Orn I., Wolpe S., Garcia-Bustos J., Hoffmann M., Tuomanen E. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect. Immun. 57:1989;1890-1893.
6. Burroughs M., Cabellos C., Prasad S., Tuomanen E. Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in Gram-negative meningitis? J. Infect. Dis. 165:1992;S82-85.
7. •] shows that the interaction enhances monokine production.
8. Heumann D., Barras C., Severin A., Glauser M., Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor α and interleukin-6 by human monocytes. Infect. Immun. 62:1994;2715-2721.
9. Freyer D., Manz R., Ziegenhorn A., Weih M., Angstwurm K., Docke W., Meisel A., Schumann R., Schonfelder G., Dirnagl U.et al. Cerebral endothelial cells release TNFα after stimulation with cell walls of Streptococcus pneumoniae and regulate iNOS and ICAM-1 expression via autocrine loops. J. Immunol. 163:1999;4308-4314.
10. van der Flier M., Coenjaerts F., Kimpen J., Hoepelman A., Geelen S. Streptococcus pneumoniae induces secretion of vascular endothelial growth factor by human neutrophils. Infect. Immun. 68:2000;4792-4794.
11. Morath S., Stadelmaier A., Geyer A., Schmidt R., Hartung T. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195:2002;1635-1640 This is the first report of an entirely synthesized lipoteichoic acid. Cytokine-releasing activity required a lipid anchor and a substitution of the backbone with D-alanine.
12. Spellerberg B., Rosenow C., Sha W., Tuomanen E. Pneumococcal cell wall activates NF-κB in human monocytes. Microb. Pathog. 20:1996;309-317.
13. Dziarski R., Jin Y., Gupta D. Differential activation of ERK-1, ERK-2, p38, and cJun amino terminal kinase MAP kinases by bacterial peptidoglycan. J. Infect. Dis. 174:1996;777-785.
14. Schumann R., Pfeil D., Freyer D., Buerger W., Lamping N., Kirschning C., Goebel U., Weber J. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen-activated protein kinases (MAPK) ERK-1, ERK-2, and p38 in astrocytes. Glia. 22:1998;295-305.
15. Opitz B., Schroeder N., Spreitzer I., Michelsen K., Kirschning C., Hallatschek W., Zahringer U., Hartung T., Goebel U., Schumann R. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J. Biol. Chem. 276:2001;22041-22047.
16. Draheim H., Prinz M., Weber J., Weiser T., Kettenmann H., Hanisch U. Induction of potassium channels in mouse brain microglia: cells acquire responsiveness to pneumococcal cell wall components during late development. Neuroscience. 89:1999;1379-1390.
17. Geelen S., Bhattacharyya C., Tuomanen E. Induction of procoagulant activity on human endothelial cells by Streptococcus pneumoniae. Infect. Immun. 60:1992;4179-4183.
18. Yipp B., Andonegui G., Howlett C., Robbins S., Hartung T., Ho M., Kubes P. Profound differences in leukocyte-endothelial cell responses to lipopolysaaccharide versus lipoteichoic acid. J. Immunol. 168:2002;4650-4658.
19. Spellerberg B., Prasad S., Cabellos C., Burroughs M., Cahill P., Tuomanen E. Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides. J. Exp. Med. 182:1995;1037-1044.
20. Morath S., Geyer A., Spreitzer I., Hermann C., Hartung T. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 70:2002;938-944 This is a seminal report documenting the fact that most of the previously used preparations of lipoteichoic acid were either contaminated with endotoxin or treated so harshly as to remove critical determinants of bioactivity. Butanol extraction is demonstrated as the best method to purify bioactive lipoteichoic acid; the authors specifically warn against commercial preparations.
21. Bahkdi S., Klonishch T., Nuber P., Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59:1991;4614-4620.
22. Keller R., Fischer W., Keist R., Bassetti S. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 60:1992;3664-3672.
23. Majcherczyk P, Rubli E, Heumann D, Glauser M, Moreillon P: Teichoic acids are not required for S. pneumoniae and S. aureus cell walls to trigger the release of TNF. Infect Immun 2003, in press.
24. Abachin E., Poyart C., Pellegrini E., Mmilohanic E., Fiedler F., Berche P., Trieu-Cuot P. Formation of the D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 43:2002;1-14.
25. Cundell D., Gerard N., Gerard C., Idanpaan-Heikkila I., Tuomanen E. Streptococcus pneumoniae anchors to activated eukaryotic cells by the receptor for platelet activating factor. Nature. 377:1995;435-438.
26. Morath S., Geyer A., Hartung T. Structure/function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193:2001;393-397.
27. •].
28. Behr T., Fischer W., Peter-Katalinic J., Egge H. Purification of lipoteichoic acid of Pneumococcus. Eur. J. Biochem. 207:1992;1063-1075.
29. Tuomanen E.I., Tomasz A., Hengstler B., Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect. Dis. 151:1985;535-540.
30. Tomasz A., Saukkonen K. The nature of cell-wall-derived inflammatory components of pneumococci. Pediatr. Infect. Dis. J. 8:1989;902-903.
31. Majcherczyk P., Langen H., Heumann D., Fountoulakis M., Glauser M., Moreillon P. Digestion of Streptococcus pneumoniae cell wall with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity. J. Biol. Chem. 274:1999;12537-12543.
32. Wolfert M., Murray T., Boons G., Moore J. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 277:2002;39179-39186.
33. Yoshimura A., Lien E., Ingalls R., Tuomanen E., Dziarski R., Golenbock D. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2. J. Immunol. 63:1999;1-5.
34. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C. Peptidoglycan- and lipoteichoic-acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:1999;17406-17409.
35. Weber J, Freyer D, Pfeil D, Kuster C, Schroeder N, Tuomanen E, Schumann R: Recognition of pneumococcal peptidoglycan, an expanded role for lipopolysaccharide binding protein. Immunity 2003, in press.
36. Garcia-Bustos J., Chait B., Tomasz A. Structure of the peptide network of pneumococcal peptidoglycan. J. Biol. Chem. 262:1987;15400-15405.
37. de Jonge B., Chang Y.-S., Gage D., Tomasz A. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. J. Biol. Chem. 267:1992;11248-11254.
38. Cauwels A., Wan E., Leismann M., Tuomanen E. Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by Gram-positive bacteria. Infect. Immun. 65:1997;3255-3260.
39. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential role of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity. 11:1999;443-451.
40. -/- mice showed a shorter time to death and a greater bacterial load in the brain than wild-type mice. This indicates a role for TLR2 in the course of Gram-positive infection in vivo.
41. Laflamme N., Soucy G., Rivest S. Circulating cell wall components derived from Gram-negative, not Gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem. 79:2001;648-657.
42. Dziarski R., Wang Q., Miyake K., Kirschnign C., Gupta D. MD-2 enables toll-like receptor 2 mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J. Immunol. 166:2001;1938-1944.
43. Sieling P., Modlin R. Toll-like receptors: mammalian 'taste receptors' for a smorgasbord of microbial invaders. Curr. Opin. Microbiol. 5:2002;70-75.
44. Wang J., Doyle M., Manning B., Wu Q., Blankson S., Redmond H. Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. J. Biol. Chem. 277:2002;36068-36075.
45. Lee H., Lee J., Tobias P. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are major components responsible for Toll-like receptor 2 mediated signaling. J. Immunol. 168:2002;4012-4017 The ability of endotoxin to signal through TLR2 has been controversial. This report indicates that previous evidence that it does have this ability is spurious in that the activity can be attributed to several lipoproteins that contaminate some endotoxin preparations.
46. Iwaki D., Mitsuzawa H., Murakami S., Sano H., Konishi M., Akino T., Kuroki Y. The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J. Biol. Chem. 277:2002;24315-24320 A soluble extracellular domain of TLR2 is shown to bind to insoluble, poorly characterized, commercially prepared staphylococcal peptidoglycan. This is the only report of such direct binding and warrants confirmation using chemically defined peptidoglycan preparations.
47. Werner T., Liu G., Kang D., Ekengren S., Steiner H., Hultmark D. A family of peptidoglycan recognition proteins in the fruit fly Drosophila melanogaster. Proc. Natl. Acad Sci. USA. 97:2000;13772-13777.
48. Michel T., Reichhart J., Hoffmann J., Royet J. Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein. Nature. 414:2001;756-759.
49. Kang D., Liu G., Lundstron A., Felius E., Steiner H. A peptidoglycan recognition protein in innate immunity conserved from insects to humans. Proc. Natl. Acad Sci. USA. 95:1998;10078-10082.
50. Liu C., Gelius E., Liu G., Steiner H., Dziarski R. Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J. Biol. Chem. 275:2000;24490-24499.
51. Pugin J., Heumann D., Tomasz A., Kravchenki V., Akamatsu Y., Nishijima M., Lauser M., Tobias P., Ulevitch R. CD14 is a pattern recognition receptor. Immunity. 1:1994;509-516.
52. Gupta D., Kirkland T., Viriyakosol S., Dziarski R. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:1996;23310-23316.
53. Sugawara S., Arakaki R., Rikiishi H., Takada H. Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner. Infect. Immun. 67:1999;1623-1632.
54. Cleveland M., Gorham J., Murphy T., Tuomanen E., Murphy K. Lipoteichoic acids of Gram-positive bacteria induce interleukin-12 through CD-14 dependent pathway. Infect. Immun. 64:1996;1906-1912.
55. Weidemann G., Schletter J., Dziarski R., Kusumoto S., Stelter F., Rietschel E., Flad H., Ulmer A. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect. Immun. 65:1997;858-864.
56. Cauwels A., Frei K., Sansano S., Fearns C., Ulevitch R., Simmerli W., Landmann R. The origin and function of soluble CD14 in experimental bacterial meningitis. J. Immunol. 162:1999;4762-4772.
57. Ramadan M., Shrive A., Holden D., Myles D., Volanakis J., DeLucas L., Greenhough T. The three-dimensional structure of calcium-depleted human C-reactive protein from perfectly twinned crystals. Acta Crystallogr. 58:2002;992-1001.
58. Mold C., Rodic-Polic B., Du Clos T. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ receptors. J. Immunol. 168:2002;6375-6381.
59. Gould J., Weiser J. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating-factor receptor-mediated adherence is blocked by surfactant. J. Infect. Dis. 186:2002;361-371 CRP binds the phosphorylcholine on pneumococcal lipoteichoic acid, leading to inhibition of the adherence of the bacteria to the PAF receptor that is required for bacterial invasion. Surfactant, which contains abundant phosphorylcholine, competes with CBP and decreases lung defenses. This work extends our knowledge of the in vivo biological significance of adducts to lipoteichoic acids.
60. Lemjabbar H., Basbaum C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat. Med. 8:2002;41-46 This report extends our recognition of the interaction of lipoteichoic acid with the PAF receptor from pneumococci to staphylococci. Signaling downstream of this interaction may activate bacterial uptake or increase metalloproteinase production, depending on the pathogen. This indicates that pathways independent of TLR2 contribute to Gram-positive disease.
61. van der Laan L., Dopp E., Haworth R., Pikkarainen T., Kangas M., Elomaa O., Dijkstra D., Grodon S., Tryggvason K., Kraal G. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J. Immunol. 162:1999;939-947.
62. Dunne D., Resnick D., Greenberg J., Kriefer M., Joiner K. The type I macrophage scavenger receptor binds to Gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad Sci. USA. 91:1994;1863-1867.
63. Shimaoka T., Kume N., Minami M., Hayashida K., Sawamura T., Kita T., Yonehara S. LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. J. Immunol. 166:2001;5108-5114.
64. Polotsky V., Fischer W., Ezekowitz R., Joiner K. Interactions of human mannose-binding protein with lipoteichoic acids. Infect. Immun. 64:1996;380-383.
65. Palaniyar N., Nadesalingam J., Reid K. Pulmonary innate immune proteins and receptors that interact with Gram-positive bacterial ligands. Immunobiology. 205:2002;575-594.
66. Tunkel A., Scheld W. Corticosteroids for everyone with meningitis? N. Engl. J. Med. 347:2002;1613-1614.
67. de Gans J., van de Beek D. Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 347:2002;1549-1556.
68. Fischer W: Pneumococcal Lipoteichoic Acid and Teichoic Acid. Edited by Tomasz A. Larchmont, NY: Mary Ann Liebert, Inc; 2000.
69. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., Schroeder L., Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad Sci. USA. 97:2000;13766-13771.
70. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., Underhill D.M. Collaborative induction of inflammatory responses by Dectin-1 and Toll-like receptor 2. J. Exp. Med. 197:2003;1107-1117.